CoChat

Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment study

Open access
Loschi, Michael, Porcher, Raphael, Barraco, Fiorenza, Terriou, Louis, Mohty, Mohamad, de Guibert, Sophie, Mahe, Beatrice, Lemal, Richard, Dumas, Pierre‐Yves, Etienne, Gabriel, Jardin, Fabrice, Royer, Bruno, Bordessoule, Dominique, Rohrlich, Pierre Simon, Fornecker, Luc Mathieu, Salanoubat, Celia, Maury, Sebastien, Cahn, Jean‐Yves, Vincent, Laure, Sene, Thomas, Rigaudeau, Sophie, Nguyen, Stephanie, Lepretre, Anne‐Claire, Mary, Jean‐Yves, Corront, Bernadette, Socie, Gerard, Peffault de Latour, Regis · 2016 · American Journal of Hematology
Cited by 148

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Intravascular hemolysis in Paroxysmal nocturnal hemoglobinuria (PNH) can effectively be controlled with eculizumab, a humanized monoclonal antibody that binds complement protein C5. We report here a retrospective comparison study between 123 patients treated with eculizumab in the recent period (>2005) and 191 historical controls (from the French registry). Overall survival (OS) at 6 years was 92% (95%CI, 87 to 98) in the eculizumab cohort versus 80% (95%CI 70 to 91) in historical controls diagnosed after 1985 (HR 0.38 [0.15 to 0.94],P = 0.037). There were significantly fewer thrombotic events (TEs) in the group of patients treated with eculizumab (4% [1–10]) as compared to the historical cohort (27% [20–34]). However, we found that TEs may still occur after the initiation of eculizumab treatment and that previous TEs still have a negative impact on survival. Evolutions to myelodysplastic syndrome or acute leukemia were similar in both cohorts. There was less evolution to aplastic anemia in the treatment group. In multivariate analysis, absence of a previous TE and treatment with eculizumab were associated with a better OS. Treatment with eculizumab improves overall survival in classic PNH patients without increasing the risk of clonal evolution. Am. J. Hematol. 91:366–370, 2016. © 2016 Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajh.24278

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Loschi, M., Porcher, R., Barraco, F., Terriou, L., Mohty, M., de Guibert, S., Mahe, B., Lemal, R., Dumas, P., Etienne, G., Jardin, F., Royer, B., Bordessoule, D., Rohrlich, P. S., Fornecker, L. M., Salanoubat, C., Maury, S., Cahn, J., Vincent, L., Sene, T., Rigaudeau, S., Nguyen, S., Lepretre, A., Mary, J., Corront, B., Socie, G., & Peffault de Latour, R.
Venue
American Journal of Hematology
Publisher
Wiley
Published
2016-03-18
Volume
91
Issue
4
Pages
366-370
ISSN
  • 0361-8609 (ISSN-L)
  • 1096-8652
OpenAlex
W2209557348
Cited by
148
References
3
FWCI
5.50
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.